From Breakthrough Science to Public Trust: A CEO’s Perspective on Communicating Innovation

Session details:

As biotech breakthroughs accelerate—from microbiome therapeutics to AI-driven medicine—communications leaders are increasingly responsible for translating complex science into narratives that build trust and inspire participation. In this session, Stephanie Culler, CEO of Persephone Biosciences, shares lessons from the frontlines of innovation, offering a scientist-executive perspective on how storytelling, transparency, and community engagement shape the success of emerging therapies.

Attendees will gain insight into how communications leaders can effectively partner with scientific leadership to bring cutting-edge innovation to life for patients, partners, and the public.